Glycine tab. podyaz . 100mg # 100

Release form

Sublingual tablets

pharmachologic effect

Metabolic drug.

Glycine is a regulator of metabolism, normalizes and activates the processes of protective inhibition in the central nervous system, reduces psycho-emotional stress, and increases mental performance.

Glycine has glycine- and GABA-ergic, alpha1-adrenergic blocking, antioxidant, antitoxic effects

regulates the activity of glutamate (NMDA) receptors, due to which the drug is able to:

- reduce psychoemotional stress, aggressiveness, conflict, increase social adaptation

- improve mood

- facilitate falling asleep and normalize sleep

- improve mental performance

- to reduce vegetative-vascular disorders (including in the climacteric period)

- reduce the severity of brain disorders in ischemic stroke and traumatic brain injury

- to reduce the toxic effect of alcohol and other drugs that depress the function of the central nervous system.

Indications

- reduced mental performance

- stressful situations - psychoemotional stress (during exams, conflict situations, etc.)

- deviant forms of behavior of children and adolescents

- various functional and organic diseases of the nervous system accompanied by increased excitability, emotional instability, decreased mental performance and sleep disturbances: neuroses, neurosis-like states and vegetative-vascular dystonia, the consequences of neuroinfections and traumatic brain injury, perinatal and other forms of encephalopathies (including . alcoholic genesis)

- ischemic stroke.

Contraindications

- individual hypersensitivity to drug components.

Structure

Sublingual tablets of white color with elements of marbling, flat-cylindrical shape with bevel.

1 tablet:

microencapsulated glycine 100 mg

Excipients: magnesium stearate 1 mg, water-soluble methylcellulose 1 mg.

Method of administration and dosage

Glycine is applied sublingually or buccal 100 mg (in tablets or as a powder after crushing the tablet).

For practically healthy children, adolescents and adults with psychoemotional stress, memory loss, attention, mental performance, mental retardation, with deviant forms of behavior, Glycine is prescribed 1 tab.

2-3 times / day for 14-30 days.

With functional and organic lesions of the nervous system, accompanied by increased excitability, emotional lability and sleep disturbance, children under three years of age are prescribed 0.5 tab.

(50 mg) 2-3 times / day for 7-14 days, then 50 mg 1 time / day for 7-10 days.

The daily dose is 100-150 mg, the course dose is 2000-2600 mg.

Children over 3 years old and adults are prescribed 1 tab.

2-3 times / day, the course of treatment is 7-14 days.

The course of treatment can be increased to 30 days, if necessary, the course is repeated after 30 days.

For sleep disorders, Glycine is prescribed 20 minutes before bedtime or immediately before bedtime, 0.5-1 tab.

(depending on age).

With ischemic cerebral stroke: during the first 3-6 hours from the development of a stroke, 1000 mg is prescribed buccal or sublingually with one teaspoon of water, then 1000 mg / day for 1-5 days, then 1-2 tablets for the next 30 days ...

3 times / day

In narcology, Glycine is used as a means of increasing mental performance and reducing psychoemotional stress during remission with symptoms of encephalopathy, organic lesions of the central and peripheral nervous system, 1 tab.

2-3 times / day for 14-30 days.

If necessary, courses are repeated 4-6 times a year.

Side effects

Allergic reactions are possible.

Storage conditions

The drug should be stored in a dry, dark place, out of the reach of children, at a temperature not exceeding 25 ° C.

Shelf life

3 years

Active substance

Glycine

Dosage

100mg

Structure

Tablets sublingual white with elements of marbling, flat-cylindrical shape with a bevel. 1 tablet: microencapsulated glycine 100 mg. Excipients: magnesium stearate 1 mg, water-soluble methylcellulose 1 mg.

Indications

Decreased mental performance

stressful situations psychoemotional stress (during exams, conflict situations, etc.)

deviant forms of behavior of children and adolescents

various functional and organic diseases of the nervous system accompanied by increased excitability, emotional instability, decreased mental performance and sleep disturbance: neuroses, neurosis-like conditions and vegetative-vascular dystonia, the consequences of neuroinfections and traumatic brain injury, perinatal and other forms of encephalopathies (incl. alcoholic genesis)

ischemic stroke

Storage conditions and periods

At a temperature not exceeding 25 degrees, in the original packaging.

Expiration date: 3 years

INN / Active ingredient

Glycine

Contraindications

individual hypersensitivity to drug components.

Specifications

Category

Sedatives

,

Antipsychotics

,

Neurological disorders

Scope of the drug

General

Release form

Tablet

Manufacturer country

Russia

Package quantity, pcs

one hundred

Vacation conditions

Without recipe

Brand name

Biotics Mnpk

The amount of the dosage form in the primary package

50 pcs.

Primary packaging type

Blister

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

Metabolic agent

Anatomical and therapeutic characteristics

N06BX Other psychostimulants and nootropics

Dosage form

Sublingual tablets

Dosage (volume) of the substance in the preparation

1 tablet: microencapsulated glycine 100 mg

The target audience

Children

Expiration date in days

1095

Package weight, g

ten

Mode of application

:

Glycine is applied sublingually or buccal 100 mg (in tablets or in powder form after crushing the tablet). For practically healthy children, adolescents and adults with psychoemotional stress, memory loss, attention, mental performance, mental retardation, with deviant forms of behavior, Glycine is prescribed 1 tab. 2-3 times / day for 14-30 days. < br> With functional and organic lesions of the nervous system, accompanied by increased excitability, emotional lability and sleep disturbance, children under three years of age are prescribed 0.5 tab. (50 mg) 2-3 times / day for 7-14 days, then 50 mg 1 time / day for 7-10 days. The daily dose is 100-150 mg, the course dose is 2000-2600 mg. Children over 3 years old and adults are prescribed 1 tab. 2-3 times / day, the course of treatment is 7-14 days.The course of treatment can be increased to 30 days, if necessary, the course is repeated after 30 days. < br> For sleep disorders, Glycine is prescribed 20 minutes before bedtime or just before bedtime, 0.5-1 tab. (depending on age). < br> In ischemic cerebral stroke: during the first 3-6 hours from the development of stroke, 1000 mg is prescribed buccal or sublingually with one teaspoon of water, then 1000 mg / day for 1-5 days, then over the next 30 days 1-2 tab. 3 times / day. < br> In narcology Glycine is used as a means of increasing mental performance and reducing psycho-emotional stress during remission with symptoms of encephalopathy, organic lesions of the central and peripheral nervous system, 1 tab. 2-3 times / day for 14-30 days. If necessary, courses are repeated 4-6 times a year. < br>

Information on technical characteristics, delivery set, country of manufacture